Literature DB >> 19248769

Gastric acid reduction leads to an alteration in lower intestinal microflora.

Takayuki Kanno1, Takahiro Matsuki, Masashi Oka, Hirotoshi Utsunomiya, Kenichi Inada, Hirohito Magari, Izumi Inoue, Takao Maekita, Kazuki Ueda, Shotaro Enomoto, Mikitaka Iguchi, Kimihiko Yanaoka, Hideyuki Tamai, Shigeru Akimoto, Koji Nomoto, Ryuichiro Tanaka, Masao Ichinose.   

Abstract

To clarify the alterations in lower intestinal microflora induced by gastric acid reduction, the dynamics of 12 major genera or groups of bacteria comprising the microflora in feces and colonic contents were examined by quantitative real-time PCR in proton pump inhibitor-treated rats and in asymptomatic human subjects with hypochlorhydria. In both rat and human experiments, most genera or groups of intestinal microflora (facultative and obligate anaerobes) proliferated by gastric acid reduction, and marked and significant increases in the Lactobacilli group and Veillonella, oropharyngeal bacteria, were observed. In rats, potent gastric acid inhibition led to a marked and significant increase of intestinal bacteria, including the Bacteroidesfragilis group, while Bifidobacterium, a beneficial bacterial species, remained at a constant level. These results strongly indicate that the gastric acid barrier not only controls the colonization and growth of oropharyngeal bacteria, but also regulates the population and composition of lower intestinal microflora.

Entities:  

Mesh:

Year:  2009        PMID: 19248769     DOI: 10.1016/j.bbrc.2009.02.109

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

Review 1.  The impact of proton pump inhibitors on the human gastrointestinal microbiome.

Authors:  Daniel E Freedberg; Benjamin Lebwohl; Julian A Abrams
Journal:  Clin Lab Med       Date:  2014-09-24       Impact factor: 1.935

2.  Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding.

Authors:  Zehra Esra Ilhan; John K DiBaise; Nancy G Isern; David W Hoyt; Andrew K Marcus; Dae-Wook Kang; Michael D Crowell; Bruce E Rittmann; Rosa Krajmalnik-Brown
Journal:  ISME J       Date:  2017-05-26       Impact factor: 10.302

3.  Helicobacter pylori infection and colorectal carcinoma: is there a causal association?

Authors:  Sergei F Tatishchev; Christine Vanbeek; Hanlin L Wang
Journal:  J Gastrointest Oncol       Date:  2012-12

4.  Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Authors:  Jasmohan S Bajaj; I Jane Cox; Naga S Betrapally; Douglas M Heuman; Mitchell L Schubert; Maiyuran Ratneswaran; Phillip B Hylemon; Melanie B White; Kalyani Daita; Nicole A Noble; Masoumeh Sikaroodi; Roger Williams; Mary M E Crossey; Simon D Taylor-Robinson; Patrick M Gillevet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-25       Impact factor: 4.052

5.  Autophagy Protects against Colitis by the Maintenance of Normal Gut Microflora and Secretion of Mucus.

Authors:  Koichiro Tsuboi; Mayo Nishitani; Atsushi Takakura; Yasuyuki Imai; Masaaki Komatsu; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2015-07-06       Impact factor: 5.157

Review 6.  Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms.

Authors:  Izumi Inoue; Jun Kato; Hideyuki Tamai; Mikitaka Iguchi; Takao Maekita; Noriko Yoshimura; Masao Ichinose
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Decompensated cirrhosis and microbiome interpretation.

Authors:  Jasmohan S Bajaj; Naga S Betrapally; Patrick M Gillevet
Journal:  Nature       Date:  2015-09-17       Impact factor: 49.962

Review 8.  Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology.

Authors:  Nicholas J Talley; Gerald Holtmann; Marjorie M Walker
Journal:  J Gastroenterol       Date:  2015-04-29       Impact factor: 7.527

9.  Effects of synbiotic supplementation on energy and macronutrients homeostasis and muscle wasting of critical care patients: study protocol and a review of previous studies.

Authors:  Najmeh Seifi; Mohammad Safarian; Mohsen Nematy; Reza Rezvani; Majid Khadem-Rezaian; Alireza Sedaghat
Journal:  Trials       Date:  2020-02-24       Impact factor: 2.279

10.  Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis.

Authors:  J S Bajaj; S M Ratliff; D M Heuman; K L Lapane
Journal:  Aliment Pharmacol Ther       Date:  2012-11       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.